Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 3/20 | 0.39 |
| ▸ | BLM | P54132 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30571293 | 1.00 | MAOA (0.56) | MAOAMAOBALOX15TDP1CDC25B | |
| SCHEMBL27214117 | 0.84 | MAOA (0.46) | MAOAMAOBALOX15TDP1CDC25B | |
| SCHEMBL4791732 | 0.82 | MAOA (0.41) | MAOAMAOBALOX15TDP1CDC25B | |
| SCHEMBL30616365 | 0.72 | MAOA (0.86) | MAOAMAOBCDC25BSMN1; SMN2KDM4E | |
| SCHEMBL9269089 | 0.72 | MAOA (0.77) | MAOAMAOBCDC25BSMN1; SMN2KDM4E | |
| SCHEMBL30956639 | 0.72 | MAOA (0.70) | MAOAMAOBCDC25BSMN1; SMN2KDM4E | |
| SCHEMBL8417659 | 0.72 | MAOA (0.86) | MAOAMAOBCDC25BSMN1; SMN2KDM4E | |
| SCHEMBL20618218 | 0.72 | MAOA (0.77) | MAOAMAOBALOX15TDP1CDC25B | |
| SCHEMBL31112247 | 0.72 | MAOA (0.77) | MAOAMAOBALOX15TDP1CDC25B | |
| SCHEMBL16685145 | 0.72 | MAOA (0.70) | MAOAMAOBTDP1CDC25BSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 726 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12620625-B2 | Electrolyte solution for lithium-ion battery and lithium-ion battery | BYD COMPANY LIMITED (CN) | 2026-05-05 | — | — | US | claimed |
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2026-01-15 | — | — | US | claimed |
| EP-4613796-A1 | STAR-SHAPED POLYMERS | Evonik Operations GmbH (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-4612150-A1 | BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-D]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | Ventus Therapeutics U.S., Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250257077-A1 | BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | VENTUS THERAPEUTICS U.S., INC. | 2025-08-14 | — | — | US | claimed |
| CN-119859264-A | Polyimide resin with controllable molecular weight and preparation method of polyimide film | 吉化集团吉林市星云化工有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119786600-A | Conductive agent, preparation method thereof, pole piece, battery pack and electric equipment | 比亚迪股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119570213-A | Environment-friendly degradable plastic-wood material and preparation method thereof | 美新科技股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-118325217-B | High-flame-retardance composite material for battery-changing cabinet and preparation method thereof | 广东众森实业发展有限公司 | 2024-09-27 | — | — | CN | claimed |
| WO-2024192754-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | 宁德新能源科技有限公司 | 2024-09-26 | — | — | WO | claimed |
| US-5863980-A | REACTING AN ANHYDRIDE WITH DIOL OR TRIOL OR AN ANHYDRIDE WITH DOUBLE BOND AND TRIOL OR TETROL FORMING DIOL OR TRIOL MONOMERS, WHICH REACT WITH POLYOL AND DIISOCYANATE TO GIVE POLYURETHANE PREPOLYMER, CHAIN EXTENDING, ULTRAVIOLET CURING | HEPCE CHEM CO., LTD. (KR) | 1999-01-26 | — | — | US | claimed |
| EP-0876369-A1 | 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1998-11-11 | — | — | EP | claimed |
| EP-0503537-B1 | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones | UNIV VERMONT (US) | 1997-05-14 | — | — | EP | claimed |
| WO-1997010245-A1 | 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1997-03-20 | — | — | WO | claimed |
| US-5532328-A | Process for the preparation of a polymer | DSM N.V. (NL) | 1996-07-02 | — | — | US | claimed |
| EP-0633903-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1995-01-18 | — | — | EP | claimed |
| WO-1994017120-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1994-08-04 | — | — | WO | claimed |
| EP-0575526-A1 | 6,9 BIS(SUBSTITUTED-AMINO)BENZO g]ISOQUINOLINE-5,10-DIONES | THE UNIVERSITY OF VERMONT (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1992015300-A1 | 6,9 BIS(SUBSTITUTED-AMINO)BENZO[g]ISOQUINOLINE-5,10-DIONES | THE UNIVERSITY OF VERMONT (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0503537-A1 | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones | THE UNIVERSITY OF VERMONT (US) | 1992-09-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257077-A1 | BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | NLRP3, NLRP1, NOD1 | MAOA 1167/4885MAOB 933/4885ALOX15 1910/4885 |
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | CACNA2D3, VMP1, CACNA2D2 | MAOA 3538/4885MAOB 2068/4885ALOX15 3163/4885 |
| US-12620625-B2 | Electrolyte solution for lithium-ion battery and lithium-ion battery | SLC9A1, HCN4, HCN1 | MAOA 2479/4885MAOB 1552/4885ALOX15 3096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.